CASE REPORT
Tuberculosis infection in children with proteinuria/nephrotic syndrome
Submission date: 2017-08-02
Final revision date: 2017-10-16
Acceptance date: 2017-10-17
Publication date: 2017-10-30
Cent Eur J Immunol 2017;42(3):318-323
KEYWORDS
ABSTRACT
Children with nephrotic syndrome (NS) are at greater risk of infections than the general population, due to immunodeficiency in the course of the disease and the treatment. In this study we present 4 children (2 girls, 2 boys), mean age 7.6 ±5.1 years, with NS/proteinuria and latent tuberculosis in 3 children and lymph node tuberculosis in 1 child. The reasons for testing these children for tuberculosis (TB) were the evaluation of the epidemiological status before treatment with corticosteroids (GCS), leukopenia and the relapse of NS, and non-nephrotic proteinuria. The diagnosis of TB infection was based on positive IGRA (Interferon-Gamma Release Assay). Chest X-ray was normal in all the children. Chest CT scan revealed an enlargement of lymph nodes in 1 child. The children were treated with isoniazid (3 children) and isoniazid, rifampicin and pyrazinamide (1 child). Three children with idiopathic nephrotic syndrome were treated with prednisone. The child with non-nephrotic proteinuria was treated with enalapril. Proteinuria disappeared in all children during anti-TB treatment.
REFERENCES (28)
1.
World Health Organization. WHO Global Tuberculosis Report 2016. http://www.who.int/tb/publicat....
2.
Erkens CG, Kamphorst M, Abubakar I, et al. (2010): Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J 36: 925-949.
3.
Korzeniewska-Koseła M. Gruźlica w Polsce w 2016 roku. Biuletyn IGiChP.www.igichp.edu.pl/pobierz/Biuletyn_2017.zip.
4.
Augustynowicz-Kopeć E, Zwolska Z (2008): Epidemiologia gruźlicy u dzieci i niektóre problemy diagnostyki mikrobiologicznej. Post Nauk Med 9: 569-577.
5.
World Health Organization Guidelines on the Management of Latent Tuberculosis Infection. Geneva, Switzerland: WHO, 2015.http://www.who.int/tb/publicat....
6.
Tuberculosis. In: Red Book: 2012 Report of the Committee on Infectious Diseases.Pickering LK, Baker CJ, Kimberlin DW, Long SS (eds.). American Academy of Pediatrics. ElkGroveVillage, IL. 2012: 736-759.
7.
Augustynowicz-Kopeć E, Demkow U, Grzelewska-Rzymowska I, et al. (2013): Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące rozpoznawania, leczenia i zapobiegania gruźlicy u dorosłych i dzieci. Pneumonol Alergol Pol 81: 323-379.
8.
Bielecka T, Komorowska-Piotrowska A, Mazur A (2015): Współczesna diagnostyka zakażenia prątkiem gruźlicy u dzieci – czy nadal odczyn tuberkulinowy? Postępy Hig Med. Dosw 69: 1130-1139.
9.
Pendzich J, Maksymowicz-Mazur W, Kozielski J (2011): Postępy we współczesnej diagnostyce laboratoryjnej gruźlicy. J Lab Diag 47: 439-446.
10.
QuantiFERON®-TB Gold (QFT®) Package Insert. http://www.quantiferon.com/wp-..._ ELISA_R04_082016.pdf.
12.
Borkowska D, Zwolska Z, Michałowska-Mitczuk D, et al. (2011): Interferonowy test T-SPOT.TB w diagnostyce latentnego zakażenia prątkiem gruźlicy. Pneumonol Alergol Pol 79: 264-271.
13.
Thillai M, Pollock K, Pareek M, et al. (2014): Interferon-gamma release assays for tuberculosis: current and future applications. Expert Rev Respir Med 8: 67-78.
14.
Sollai S, Galli L, de Martino M, et al. (2014): Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update. BMC Infect Dis 14 (Suppl.1): S6.
15.
Pac M, Bustamante J, Buda P, et al. (2012): Disseminated Mycobacterium tuberculosis complex infection in a girl with partial dominant IFN- receptor 1 deficiency. Centr Eur J Immunol 37: 378-381.
16.
Beck L, Bomback AS, Choi MJ, et al. (2013): KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis. Am J Kidney Dis 62: 403-441.
18.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012): KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney int Suppl 2: 139-274.
19.
Lombel RM, Gipson DS, Hodson EM (2013): Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28: 415-426.
20.
Lombel RM, Hodson EM, Gipson DS (2013): Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol 28: 409-414.
21.
Ziółkowska H, Bałasz-Chmielewska I, Grenda R, et al. (2015): Zalecenia Polskiego Towarzystwa Nefrologii Dziecięcej (PTNFD) dotyczące postępowania z dzieckiem z zespołem nerczycowym. Forum Nefrologiczne 8: 238-256.
22.
Kemper MJ, Zepf K, Klaassen I, et al. (2005): Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse. Am J Nephrol 25: 132-136.
23.
Lambie SH, Cassidy MJ (2003): Minimal change nephropathy and renal tuberculosis. Clin Nephrol 60: 439-440.
24.
Kobashi Y, Matsushima T (2002): Clinical analysis of pulmonary tuberculosis in association with corticosteroid therapy. Intern Med 41: 1103-1110.
25.
Schwartz GJ, Muńoz A, Schneider MF, et al. (2009): New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20: 629-637.
26.
Figueiredo AA, Lucon AM (2008): Urogenital tuberculosis: update and review of 8961 cases from the world literature. Rev Urol 10: 207-217.
27.
Mazur A. Gruźlica układu moczowego. In: Gruźlica dziecięca. Ziołkowski J (ed.). Borgis, Warszawa 2010.
28.
Gipson DS, Massengil SF, Yao L, et al. (2009): Management of childhood onset nephrotic syndrome. Pediatrics 124: 747-757.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
